Investing.com - Financial Markets Worldwide
Open in App

Recce Ltd (RCE)

Sydney
Currency in AUD
0.540
0.000(0.00%)
Closed·
RCE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.5350.540
52 wk Range
0.2800.730
Key Statistics
Edit
Bid/Ask
0.51 / 0.54
Prev. Close
0.54
Open
0.54
Day's Range
0.535-0.54
52 wk Range
0.28-0.73
Volume
27.14K
Average Volume (3m)
95.54K
1-Year Change
89.4737%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RCE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
Short term obligations exceed liquid assets
Unlock InvestingPro

Recce Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Recce Company Profile

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States. The company’s lead candidate is RECCE 327 (R327) for the treatment of life-threatening bacterial infections. In addition, its product pipeline comprises R327 Intravenous, which is in Phase I and Phase I/II clinical trial for the treatment of urinary tract infections/urosepsis; and R327 Topical Gel, which is Phase II clinical trial for the treatment of acute bacterial skin and skin structure infections, as well as is in Phase I/II clinical trials for topical wound infections and diabetic foot infections. The company has strategic partnership with Murdoch Children’s Research Institute for development of the Acinetobacter baumannii and Mycobacterium abscessus; and cooperative research and development agreement with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to be tested against highly hazardous pathogens. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Industry
Pharmaceuticals
Sector
Healthcare
Market
Australia

Compare RCE to Peers and Sector

Metrics to compare
RCE
Peers
Sector
Relationship
P/E Ratio
−5.2x−8.9x−0.5x
PEG Ratio
0.220.010.00
Price/Book
−8.4x3.3x2.6x
Price / LTM Sales
160.2x17.6x3.2x
Upside (Analyst Target)
344.4%187.4%47.4%
Fair Value Upside
Unlock3.3%6.9%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
27-02-2026
EPS / Forecast
-0.06 / --
Revenue / Forecast
412.04K / --
EPS Revisions
a
a
Unlock
Last 90 days

RCE Income Statement

FAQ

What Is the Recce (RCE) Share Price Today?

The Recce share price today is 0.540.

What is the current Recce (RCE) share price and day range?

As of 28-04-2026, the Recce share price is 0.540, with a previous close of 0.540. The share price has ranged from 0.535 to 0.540 today, while the 52-week range spans from 0.280 to 0.730.

What Is the Recce Market Cap?

As of today, Recce market cap is 156.160M.

What Is the Recce (RCE) Share Price Target?

The average 12-month share price target for Recce is 2.400, with a high estimate of 2.4 and a low estimate of 2.4. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +344.44% Upside potential.

What Is Recce's Earnings Per Share (TTM)?

The Recce EPS (TTM) is -0.113.

From a Technical Analysis Perspective, Is RCE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Recce Trade On?

Recce is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Recce?

The stock symbol for Recce is "RCE."

How Many Times Has Recce Stock Split?

Recce has split 0 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.